title: What's new in acne and rosacea?
abstract: Acne and rosacea are common conditions seen every day by dermatologists. This review will discuss the most recent therapeutic options for patients with these conditions. Specifically, for acne, there will be a discussion of the use of isotretinoin at higher cumulative doses as well as a new formulation of isotretinoin, isotretinoin-lidose. Adult women with acne represent a growing population of patients who present for treatment of acne; the use of hormonal therapies as well as topical dapsone gel will be reviewed for these patients. For rosacea patients, the new topical agents - brimonidine gel and ivermectin cream - will be reviewed, with a discussion on possible rebound phenomenon from brimonidine. Finally, future treatments in the pipeline will be discussed.
authors.affiliation: Associate Professor of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida, USA. jkeri@med.miami.edu.|Chief, Dermatology Service, Miami VA Hospital, Miami, Florida, USA.
authors.forename: Jonette
authors.initials: J
authors.lastname: Keri
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000068438:Brimonidine Tartrate / Q000008:administration & dosage*; D003622:Dapsone / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D003880:Dermatology / Q000639:trends*; D005782:Gels / Q000008:administration & dosage; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage*; D007559:Ivermectin / Q000008:administration & dosage; D012393:Rosacea / Q000188:drug therapy*; D063465:Skin Cream / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D005782:Gels; D000068438:Brimonidine Tartrate; D007559:Ivermectin; D003622:Dapsone; D015474:Isotretinoin